KOE:243070

Huons Co., Ltd. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 12:47 UTC

Last close

n/aKRW

Market data

  • 4.4xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed
    • Computed from the filing for 2025
  • 8.0%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 6.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 4.0%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.48Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed

Five bars, one line

lens 7 of 9
1.46x
1.17x
2.82x
1.99x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.46x

    Its own average over 10 years, 424.64B.

  • Profit1.17x

    Its own average over 10 years, 36.52B.

  • Free cash flow2.82x

    Its own average over 10 years, 8.85B.

  • Debt1.99x

    Its own average over 10 years, 89.71B.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 2.82 times.

Sales is 1.46 times its own 10-year average; Profit is 1.17 times its own 10-year average; Free cash flow is 2.82 times its own 10-year average; Debt is 1.99 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average1.46
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Profit against its own 10-year average1.17
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Free cash flow against its own 10-year average2.82
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Debt against its own 10-year average1.99
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    KRW

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.